Answers are grounded in this paper and cite their sources.
The purpose of this review is to determine the risk of vascular occlusion due to either in situ thrombosis or thromboembolism in patients with major ventricular dysfunction with or without heart failure, and to determine whether such events can be reduced by ant it hrombotic therapy.
No takes yet. Share an insight, caveat, or question.
John G.F. Cleland (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: